Warning letter
BioMerieux, Inc.: warning letter of Jul 29, 2005
FDA warning letter UCM075502 · Office of Enforcement
Key facts
| Reference number | UCM075502 |
|---|---|
| Company | BioMerieux, Inc. |
| Subject | CGMP/IVR Manufacturing |
| Issue date | Jul 29, 2005 |
| Posted date | Jul 29, 2005 |
| Issuing office | Office of Enforcement |
| Product type | Unknown |
| Country | 3 |
| Inspection city | Durham |
| Inspection ZIP | 27712-9402 |
| Inspection start date | Mar 15, 2005 |
| Letter on fda.gov | web.archive.org |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: